Hemophilia A
67 results
1 - 67
Hemophilia A
Transfusion Therapy - Special Considerations
concizumab- antihemophilic factor
- Factor VIII assay
- antihemophilic (recombinant), porcine sequence
- emicizumab
- antihemophilic factor (recombinant) Fc fusion protein
- Desmopressin Acetate (DDAVP)
- coagulation factor IX (Recombinant), Fc fusion protein
- desmopressin
- factor ix (human)
- nelfinavir
- caplacizumab
- indinavir
- pentosan
- BLEEDING DISORDERS: LABORATORY EVALUATION
- Evaluating the Patient Before Anesthesia - Review of Systems
- Partial thromboplastin time
- ritonavir
- meningococcal polysaccharide diphtheria toxoid conjugate vaccine
- tipranavir
- amprenavir
- Transfusion Therapy - Pharmacologic Therapy
- Factor assays (coagulation factor assays)
- ombitasvir/paritaprevir/ritonavir/dasabuvir
- darunavir/cobicistat/emtricitabine/tenofovir alafenamide
- alemtuzumab
- Transfusion Therapy - Coagulation Studies
- Inhibitor screen (1:1 mix)
- atazanavir
- saquinavir
- ombitasvir/paritaprevir/ritonavir
- atazanavir/cobicistat
Generalized Bleeding, Coagulopathy and Transfusion Medicine- Transfusion Therapy - Perioperative Coagulopathy
- Transfusion Therapy - Complications of Blood Transfusion Therapy
- Transfusion Therapy - Blood Component Therapy
- ARTHRITIS: EXAMINATION AND CLASSIFICATION OF SYNOVIAL (JOINT) FLUID
- TRANSFUSION: SUMMARY CHART OF BLOOD COMPONENT THERAPY